SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 398 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $52,078,000 | +43.4% | 266,129 | +24.6% | 0.03% | +14.8% |
Q2 2020 | $36,307,000 | +141.0% | 213,670 | +63.7% | 0.03% | +80.0% |
Q1 2020 | $15,063,000 | +0.6% | 130,560 | -0.4% | 0.02% | -28.6% |
Q4 2019 | $14,979,000 | +1810.6% | 131,097 | +1327.3% | 0.02% | +2000.0% |
Q3 2019 | $784,000 | +47.9% | 9,185 | +19.9% | 0.00% | 0.0% |
Q2 2019 | $530,000 | -68.5% | 7,663 | -66.6% | 0.00% | -66.7% |
Q1 2019 | $1,680,000 | -37.0% | 22,959 | -33.6% | 0.00% | -40.0% |
Q3 2018 | $2,668,000 | +1207.8% | 34,596 | +786.4% | 0.01% | +400.0% |
Q1 2018 | $204,000 | -56.6% | 3,903 | -55.6% | 0.00% | 0.0% |
Q4 2017 | $470,000 | -20.2% | 8,785 | -18.8% | 0.00% | -50.0% |
Q3 2017 | $589,000 | -21.3% | 10,821 | -25.1% | 0.00% | -33.3% |
Q2 2017 | $748,000 | -25.1% | 14,455 | -23.6% | 0.00% | -25.0% |
Q4 2016 | $998,000 | +105.8% | 18,909 | +110.4% | 0.00% | +100.0% |
Q3 2016 | $485,000 | -81.4% | 8,986 | -84.5% | 0.00% | -87.5% |
Q4 2015 | $2,605,000 | +263.8% | 58,055 | +292.3% | 0.02% | +220.0% |
Q2 2015 | $716,000 | – | 14,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 28,876,712 | $1,020,792,000 | 8.49% |
Lagoda Investment Management, L.P. | 617,204 | $21,818,000 | 5.84% |
Redmile Group, LLC | 1,052,666 | $37,212,000 | 3.34% |
Opus Point Partners Management, LLC | 111,050 | $3,926,000 | 3.29% |
SOUND ENERGY PARTNERS, INC. | 10,000 | $354,000 | 2.33% |
EMORY UNIVERSITY | 29,535 | $1,044,000 | 1.97% |
SECTORAL ASSET MANAGEMENT INC | 1,260,275 | $44,551,000 | 1.69% |
CORRADO ADVISORS, LLC | 104,175 | $3,683,000 | 1.59% |
WASATCH ADVISORS LP | 3,462,749 | $122,408,000 | 1.27% |
Baillie Gifford | 15,253,520 | $539,213,000 | 1.02% |